ストックスクリーナーアプリを入手
247.79
3.34%
8.01
アフターアワーズ：
247.79
前日終値:
$239.78
開ける：
$244.54
24時間の取引高:
961.35K
Relative Volume:
1.15
時価総額：
$36.40B
収益：
$4.81B
当期純損益:
$1.11B
株価収益率:
32.82
EPS:
7.55
ネットキャッシュフロー:
$1.35B
1週間 パフォーマンス:
+8.29%
1か月 パフォーマンス:
+4.43%
6か月 パフォーマンス:
+21.97%
1年 パフォーマンス:
+43.61%
1日の値動き範囲:
$243.88
$249.31
1週間の範囲:
$229.09
$249.31
52週間の値動き範囲:
$170.56
$260.49
Resmed Inc Stock (RMD) Company Profile
RMD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
247.79 | 36.40B | 4.81B | 1.11B | 1.35B | 7.55 |
|
ISRG
Intuitive Surgical Inc
|
604.12 | 215.18B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
240.37 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
88.54 | 43.79B | 9.76B | 1.16B | 665.00M | 2.34 |
|
WST
West Pharmaceutical Services Inc
|
344.69 | 25.00B | 2.88B | 499.60M | 321.60M | 6.74 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-16 | 開始されました | Goldman | Buy |
| 2025-01-10 | 開始されました | Piper Sandler | Neutral |
| 2024-12-13 | 開始されました | Stifel | Hold |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-09-18 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | ダウングレード | Needham | Buy → Hold |
| 2024-06-25 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2024-06-24 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-02-06 | 再開されました | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-09-29 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | アップグレード | Needham | Hold → Buy |
| 2023-09-05 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 開始されました | UBS | Buy |
| 2023-04-14 | 開始されました | Mizuho | Buy |
| 2023-01-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-10-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-20 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-09-08 | アップグレード | Citigroup | Neutral → Buy |
| 2022-08-15 | ダウングレード | CLSA | Buy → Outperform |
| 2022-08-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-12 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-08-12 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-01-31 | アップグレード | Citigroup | Neutral → Buy |
| 2022-01-31 | アップグレード | Goldman | Neutral → Buy |
| 2022-01-28 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-01-24 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-01-13 | アップグレード | CLSA | Outperform → Buy |
| 2022-01-13 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-10-22 | アップグレード | CLSA | Underperform → Outperform |
| 2021-08-02 | ダウングレード | CLSA | Outperform → Sell |
| 2021-08-02 | ダウングレード | Needham | Buy → Hold |
| 2021-07-28 | アップグレード | Jefferies | Underperform → Hold |
| 2021-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 開始されました | RBC Capital Mkts | Underperform |
| 2021-06-28 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-06-22 | アップグレード | Macquarie | Neutral → Outperform |
| 2021-06-22 | 開始されました | Robert W. Baird | Neutral |
| 2021-06-21 | 繰り返されました | Needham | Buy |
| 2021-06-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-09 | アップグレード | CLSA | Sell → Outperform |
| 2021-05-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-05-11 | アップグレード | Citigroup | Neutral → Buy |
| 2021-04-30 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-03-16 | アップグレード | Needham | Hold → Buy |
| 2020-11-02 | アップグレード | UBS | Neutral → Buy |
| 2020-10-30 | アップグレード | JP Morgan | Underweight → Neutral |
| 2020-10-27 | アップグレード | BofA Securities | Underperform → Neutral |
| 2020-08-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2020-05-01 | アップグレード | Oppenheimer | Perform → Outperform |
| 2020-02-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 開始されました | CLSA | Underperform |
| 2020-01-31 | ダウングレード | UBS | Buy → Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Perform |
| 2019-11-22 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | アップグレード | UBS | Neutral → Buy |
| 2019-07-16 | ダウングレード | UBS | Buy → Neutral |
| 2019-05-06 | アップグレード | UBS | Neutral → Buy |
| 2019-04-18 | アップグレード | JP Morgan | Underweight → Neutral |
| 2019-01-25 | ダウングレード | Goldman | Buy → Neutral |
| 2019-01-25 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-10-26 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 開始されました | Goldman | Buy |
すべてを表示
Resmed Inc (RMD) 最新ニュース
ResMed Inc. stock rises Tuesday, outperforms market - MarketWatch
Should you buy CSL and ResMed shares in January? - The Motley Fool Australia
ResMed Inc (RMD) Stock Price Up 3.18% on Jan 21 - GuruFocus.com
ResMed Inc. (NYSE:RMD) Shares Sold by Addenda Capital Inc. - MarketBeat
Park Avenue Securities LLC Has $1.01 Million Stock Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Ritholtz Wealth Management Cuts Position in ResMed Inc. (NYSE:RMD) - MarketBeat
ChartWatch ASX Scans: Pointerra, Cyclone Metals, Ingenia Communities, Macquarie Group, Resmed, Audinate, Dicker Data, Weebit Nano - MSN
Assistive Technology Market Set to Witness Significant Growth by 2025-2032: Sunrise Medical LLC., Tobii AB, - EIN News
Assenagon Asset Management S.A. Sells 14,445 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed Inc. (NYSE:RMD) Shares Sold by Assenagon Asset Management S.A. - Defense World
ResMed Gains 37.8% in a Year: What's Driving the Stock? - MSN
Integrated Investment Consultants LLC Makes New Investment in ResMed Inc. (NYSE:RMD) - MarketBeat
ResMed (NYSE:RMD) Research Coverage Started at The Goldman Sachs Group - Defense World
1,453 Shares in ResMed Inc. (NYSE:RMD) Bought by Occidental Asset Management LLC - MarketBeat
Goldman Sachs tips ResMed shares to rocket 30% to a record high - MSN
ResMed Inc. stock rises Friday, outperforms market - MarketWatch
Goldman Sachs starts coverage on ResMed with "buy" rating - MSN
The Goldman Sachs Group Begins Coverage on ResMed (NYSE:RMD) - MarketBeat
ASX Broker Moves: Upgrades for Baby Bunting, Resmed vs Downgrades for Computershare, Monadelphous, Beach Energy - MSN
ResMed Inc. stock rises Wednesday, outperforms market - MarketWatch
Peak Financial Advisors LLC Invests $2.97 Million in ResMed Inc. (NYSE:RMD) - MarketBeat
Board of the Pension Protection Fund Makes New $915,000 Investment in ResMed Inc. (NYSE:RMD) - MarketBeat
The Zacks Analyst Blog Highlights Vertiv, Goldman Sachs, ResMed, Ralph Lauren and Amazon - Yahoo Finance
Czech National Bank Raises Stock Position in ResMed Inc. (NYSE:RMD) - Defense World
ResMed shares are up 42% in a year. This shows why they could still be great value - MSN
ResMed shares are in a two-month lull. Is this a chance to buy? - MSN
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Respiratory Devices Market Set to Witness Significant Growth by 2024-2031 | Medtronic, Hamilton Medical, - EIN News
ResMed Inc. stock falls Monday, underperforms market - MarketWatch
Zacks.com featured highlights Chipotle Mexican Grill, ResMed and ServiceNow - Yahoo Finance
ResMed CFO Executes Stock Transaction Under Rule 10b5-1 Plan - TipRanks
Brett Sandercock Sells 1,000 Shares of ResMed Inc (RMD) - GuruFocus.com
Piper Sandler Initiates Coverage on ResMed (NYSE:RMD) - Defense World
Is There An Opportunity With ResMed Inc.'s (NYSE:RMD) 31% Undervaluation? - Yahoo Finance
Piper Sandler Initiates Coverage of ResMed (RMD) with Neutral Recommendation - MSN
ResMed CFO Brett Sandercock sells shares worth $234,040 By Investing.com - Investing.com Australia
ResMed CFO Brett Sandercock sells shares worth $234,040 - Investing.com India
ResMed Inc. stock outperforms market despite losses on the day - MarketWatch
Piper Sandler Begins Coverage on ResMed (NYSE:RMD) - MarketBeat
Piper Sandler starts ResMed stock at Neutral, says execution rock solid By Investing.com - Investing.com South Africa
Piper Sandler starts ResMed stock at Neutral, says execution rock solid - Investing.com India
What 5 Analyst Ratings Have To Say About ResMed - Benzinga
ResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025 - GlobeNewswire
Sleep Study Equipment Market Seeking Excellent Growth | ResMed, - openPR
ResMed Inc. (NYSE:RMD) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
ResMed Inc. (NYSE:RMD) Given Average Recommendation of “Hold” by Brokerages - Defense World
Resmed Inc Officer Plans Further Sale of Common Shares - TipRanks
ResMed (RMD) is an Incredible Growth Stock: 3 Reasons Why - MSN
Here's Why ResMed (RMD) is a Strong Growth Stock - MSN
Birch Capital Management LLC Raises Holdings in ResMed Inc. (NYSE:RMD) - MarketBeat
Nordea Investment Management AB Acquires 215,561 Shares of ResMed Inc. (NYSE:RMD) - MarketBeat
Resmed Inc (RMD) 財務データ
収益
当期純利益
現金流量
EPS
4.94%
大文字化:
|
ボリューム (24 時間):